TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL
Condition(s):T-LGL Leukemia; Clpd-NkLast Updated:July 1, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):T-LGL Leukemia; Clpd-NkLast Updated:July 1, 2020Recruiting
Condition(s):OsteoarthritisLast Updated:August 1, 2012Completed
Condition(s):UveitisLast Updated:December 28, 2021Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:March 18, 2014Completed
Condition(s):Rheumatoid ArthritisLast Updated:July 29, 2016Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:September 16, 2014Completed
Condition(s):Primary Central Nervous System Lymphoma; PCNSL; Non Hodgkin LymphomaLast Updated:April 7, 2022Recruiting
Condition(s):Oral Lichen PlanusLast Updated:February 15, 2024Not yet recruiting
Condition(s):Primary Central Nervous System LymphomaLast Updated:September 22, 2022Recruiting
Condition(s):Uncontrolled Gout; Chronic GoutLast Updated:January 31, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.